Emmaus Life Sciences Announces Submission of Endari(r) Marketing Authorization Application in Kuwait

Source :: Plus Company Updates. July 16, 2021
Publication Year :: 2021
Abstract: TORRANCE: Emmaus Life Sciences, Inc. has issued the following news release: Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, [...]

Subjects :: Sickle cell anemia -- Drug therapy
Drug approval
Food supply
Marketing
General interest
News, opinion and commentary
Endari (Medication)

Tools